During EMT, cells gain a migratory and invasive phenotype that is characteristic for mesenchymal cells; this phenotype has been recently linked to the resistance of the tumor to radiotherapy, particularly through FOXM1 a well-known actor of this mesenchymal transition [14]. This evidence concerns the gene FOXM1 and neoplasm.